8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements

Insulet ($PODD) filed an 8‑K on Feb 18, 2026 furnishing a press release as Exhibit 99.1.

Filed with the SEC on February 18, 2026 · Summarized by InvestorsBot

Insulet ($PODD) filed an 8‑K on Feb 18, 2026 furnishing a press release as Exhibit 99.1. Filing signed by CFO Flavia H. Pease. Review the press release for material details. 📰 $PODD #Insulet #8K #MedTech

The 8‑K contains only Exhibit 99.1 (press release); no additional financial statements or other exhibits were disclosed. Investors should read the PR for any operational or financial updates. 📄 $PODD #Insulet #8K

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from INSULET CORP

Insulet ($PODD) filed a Form 8‑K on Mar 12, 2026 furnishing a press release (Exhibit 99.1) dated Mar 12, 2026.

8-K · March 12, 2026

Mar 12, 2026: Insulet ($PODD) says voluntary medical-device correction; expects up to $40M of costs, all…

8-K · March 12, 2026

Insulet ($PODD) on Feb 27, 2026 entered a severance agreement with former CFO Ana M.

8-K · March 4, 2026

On Feb 13, 2026 Insulet's Board approved a $350M increase to the prior $125M share repurchase…

8-K · February 18, 2026

Insulet ($PODD) announced Q4 & full-year 2025 financial results on Feb 18, 2026 covering the period ended…

8-K · February 18, 2026

Insulet filed an Addendum (Exhibit 10.1) effective Jan 1, 2026 to its Purchase Agreement with NXP USA, Inc.

8-K · February 3, 2026